Search for: "PFIZER" Results 1281 - 1300 of 4,632
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jun 2017, 11:27 am by Jay W. Belle Isle
., a Pfizer company, has voluntarily recalled three injectable products, as of June 15, 2017. [read post]
23 Jun 2017, 3:56 am by NCC Staff
City planners sought to transfer land to the New London Development Corporation, a private nonprofit organization, which in turn would develop the land as a new facility for Pfizer. [read post]
19 Jun 2017, 7:03 am by Robert Kraft
” Bloomberg says “Pfizer acquired the plant with its about $17 billion takeover of Hospira in 2015. [read post]
19 Jun 2017, 4:06 am by Matthew Dresden
Products as disparate as Apple’s iPhone and Pfizer’s Viagra did significant business in China as grey market goods before they were officially available there. [read post]
6 Jun 2017, 9:04 pm by Patent Docs
., a Pfizer company, for Retacrit, a proposed biosimilar to Amgen Inc.'s Epogen/Procrit (epoetin alfa). [read post]
6 Jun 2017, 1:00 am by Rik Lambers
The District Court first considered relevant decisions from the German courts (LG Hamburg 2 April 2015, Warner-Lambert v A Pharma; OLG Düsseldorf 1 December 2015, KKH v Pfizer), and UK court (England and Wales Court of Appeal 28 May 2015 and 13 October 2016, Warner-Lambert v Actavis). [read post]
4 Jun 2017, 8:24 pm
"Pfizer defeats appeals linking Zoloft to birth defects": Jonathan Stempel of Reuters has this report on a ruling that the U.S. [read post]
31 May 2017, 8:28 am
Warner-Lambert is a subsidiary of pharma giant Pfizer and it has a patent for a drug called pregabalin, sold under the trade mark Lyrica. [read post]
30 May 2017, 3:00 am by Broc Romanek
Here’s some examples from the most recent group of Form 10-Qs – note the different approaches: – Apple – Microsoft – Intel – General Electric – Coca-Cola – Pfizer – CyrusOne Links to Exhibits: SEC Staff Still Needs to Update Edgar Manual Interestingly, these companies have experimented by including links to their exhibits voluntarily – without the benefit of an updated Edgar Manual. [read post]
22 May 2017, 3:01 am
Registration closes on 25 May 2017and can be done here.London calling:  On the other side of the Channel, the Competition Law Association (CLA) will host the lunchtime event Flynn Pharma and Pfizer: the IP and competition aspects of Phenytoin Sodium Flynn on 7 July 2017 at the Arnold & Porter Kaye Scholer LLP offices in London. [read post]
12 May 2017, 10:41 am by Associated Press
And the investigation of Baxter International, Pfizer and ICU Medical over their medical pricing and dealings with competitors. [read post]
5 May 2017, 11:24 am by Lawrence B. Ebert
The CAFC decision related to cases merged from different patent challenges at the PTAB level:This appeal arises from two inter partes reexaminationsand an ex parte reexamination of U.S. [read post]
30 Apr 2017, 4:30 am
Regulatory approval, trade secrets and the transatlantic biosimilars patent wars | Biosimilars and generics as "rip-offs": when the facts may not matter | UK's IP Enforcement Framework - IPO Research Bid Opportunity | Curtain - Merpel's final EPO post | Amgen, Pfizer, Alphabet and Uber face up to trade secrets in biosimilars, self driving cars and product launch plans | BREAKING: Politico publishes (part of) draft copyright report by MEP Comodini Cachia | Parallel… [read post]
27 Apr 2017, 6:49 am by Kelly Phillips Erb
Pfizer, which repatriated the most money under the 2004 holiday laid off 3,500 employees just after the holiday and closed factories. [read post]
15 Apr 2017, 4:17 am
|Never Too Late 140 [week ending on Sunday 19 March] | Friday Fantasies | Kat konfusion regarding passing off: likelihood of confusion and the Starbucks (HK) case | Thursday Thingies | Wednesday Whimsies | First live blocking order granted in the UK |The scope of a well-known mark: not always as broad as some might wish | Monday miscellany | Around the IP Blogs | UK's IP Enforcement Framework-IPO Research Bid Opportunity (Update) Never Too Late 139 [week ending on Sunday 12… [read post]
12 Apr 2017, 2:22 pm by Tom Lamb
An Observational Study Compared Myocardial Infarction / Heart Attack Risks As Between The Use Of Newer Blood Thinners And The Use Of Warfarin   (Posted by Tom Lamb at DrugInjuryWatch.com)   In the US, there are currently four direct-acting oral anticoagulants (DOACs), a relatively new class of blood thinners, approved for the prevention of stroke in patients with atrial fibrillation (AF): Pradaxa (dabigatran) -- approved by FDA in 2010 -- Boehringer Ingelheim Pharmaceuticals Xarelto… [read post]
12 Apr 2017, 1:16 am
|Never Too Late 140 [week ending on Sunday 19 March] | Friday Fantasies | Kat konfusion regarding passing off: likelihood of confusion and the Starbucks (HK) case | Thursday Thingies | Wednesday Whimsies | First live blocking order granted in the UK |The scope of a well-known mark: not always as broad as some might wish | Monday miscellany | Around the IP Blogs | UK's IP Enforcement Framework-IPO Research Bid Opportunity (Update) Never Too Late 139 [week ending on Sunday 12 March] | Friday… [read post]